These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Involvement of ATP-sensitive K+ channels in the sustained coronary vasodilator response to adenosine in dogs. Orito K; Satoh K; Taira N Eur J Pharmacol; 1993 Feb; 231(2):183-9. PubMed ID: 8453974 [TBL] [Abstract][Full Text] [Related]
27. Mechanism of action of KRN2391 in canine coronary vascular bed. Fukata Y; Kaneta S; Okada Y; Yokoyama T; Jinno Y; Fukushima H; Ogawa N Jpn J Pharmacol; 1993 Nov; 63(3):305-11. PubMed ID: 8107323 [TBL] [Abstract][Full Text] [Related]
28. Role of K+ ATP channels and adenosine in the regulation of coronary blood flow during exercise with normal and restricted coronary blood flow. Duncker DJ; van Zon NS; Ishibashi Y; Bache RJ J Clin Invest; 1996 Feb; 97(4):996-1009. PubMed ID: 8613554 [TBL] [Abstract][Full Text] [Related]
31. Vasodilator mechanisms of action of amrinone do not involve the opening of either ATP-sensitive or Ca(2+)-activated K+ channels. Orito K; Satoh K; Taira N Tohoku J Exp Med; 1994 Feb; 172(2):163-73. PubMed ID: 7521074 [TBL] [Abstract][Full Text] [Related]
32. Possible alpha-adrenoceptor blocking activity of arotinolol (S-596), a new beta-adrenoceptor blocking agent in isolated dog coronary artery. Sakanashi M; Miyamoto Y; Ito H; Takeo S; Noguchi K; Higa T Pharmacology; 1984; 29(4):204-9. PubMed ID: 6208564 [TBL] [Abstract][Full Text] [Related]
33. Coronary vasodilator effects of BNP: mechanisms of action in coronary conductance and resistance arteries. Zellner C; Protter AA; Ko E; Pothireddy MR; DeMarco T; Hutchison SJ; Chou TM; Chatterjee K; Sudhir K Am J Physiol; 1999 Mar; 276(3):H1049-57. PubMed ID: 10070091 [TBL] [Abstract][Full Text] [Related]
34. Glibenclamide, a putative ATP-sensitive K+ channel blocker, inhibits coronary autoregulation in anesthetized dogs. Narishige T; Egashira K; Akatsuka Y; Katsuda Y; Numaguchi K; Sakata M; Takeshita A Circ Res; 1993 Oct; 73(4):771-6. PubMed ID: 8370126 [TBL] [Abstract][Full Text] [Related]
35. Effect of blockade of the ATP-sensitive potassium channel on metabolic coronary vasodilation in the dog. Aversano T; Ouyang P; Silverman H; Ziegelstein RC; Gips S Pharmacology; 1993 Dec; 47(6):360-8. PubMed ID: 8278458 [TBL] [Abstract][Full Text] [Related]
36. Mechanisms of estrogen-induced vasodilation: in vivo studies in canine coronary conductance and resistance arteries. Sudhir K; Chou TM; Mullen WL; Hausmann D; Collins P; Yock PG; Chatterjee K J Am Coll Cardiol; 1995 Sep; 26(3):807-14. PubMed ID: 7642876 [TBL] [Abstract][Full Text] [Related]
37. Comparative study of vasodilator effects of the potassium channel openers NIP-121 and levcromakalim in dogs and rats. Yamashita T; Masuda Y; Kawamura N; Fujikura N; Tanaka S Jpn J Pharmacol; 1995 Jun; 68(2):145-52. PubMed ID: 7563971 [TBL] [Abstract][Full Text] [Related]
38. Cardiovascular effects of E4080, a novel bradycardiac agent with coronary vasodilating properties, in anesthetized dogs. Kawamura T; Adachi H; Ogawa T Eur J Pharmacol; 1991 Oct; 203(3):399-404. PubMed ID: 1773825 [TBL] [Abstract][Full Text] [Related]
39. Mechanisms of vasoactive intestinal peptide-elicited coronary vasodilation in the isolated perfused rat heart. Sawmiller DR; Ashtari M; Urueta H; Leschinsky M; Henning RJ Neuropeptides; 2006 Oct; 40(5):349-55. PubMed ID: 17030371 [TBL] [Abstract][Full Text] [Related]
40. Differential effects of nitrovasodilators, K(+)-channel openers, and nicorandil on large and small coronary arteries in conscious dogs. Berdeaux A; Drieu la Rochelle C; Richard V; Giudicelli JF J Cardiovasc Pharmacol; 1992; 20 Suppl 3():S17-21. PubMed ID: 1282171 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]